Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Moodys
Teva
Chinese Patent Office
Cantor Fitzgerald
Accenture
US Department of Justice
Merck
Deloitte

Generated: January 19, 2018

DrugPatentWatch Database Preview

IOPAMIDOL-250 IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Iopamidol-250 In Plastic Container patents expire, and what generic alternatives are available?

Iopamidol-250 In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in IOPAMIDOL-250 IN PLASTIC CONTAINER is iopamidol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopamidol profile page.
Drug patent expirations by year for IOPAMIDOL-250 IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for IOPAMIDOL-250 IN PLASTIC CONTAINER

US Patents and Regulatory Information for IOPAMIDOL-250 IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira IOPAMIDOL-250 IN PLASTIC CONTAINER iopamidol INJECTABLE;INJECTION 074636-002 Dec 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Citi
Moodys
Chubb
QuintilesIMS
Colorcon
US Department of Justice
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot